WRB
Published on 07/01/2025 at 04:30
By Joshua Cooper
At the annual meeting of stockholders held on June 11, 2025, the Board of Directors of W. R. Berkley Corporation passed a resolution approving an increase in the authorized number of shares of common stock from 1.25bn to 1.88bn. In addition, the Board voted to raise the regular cash dividend to an annual rate of 36 cents per share, representing a 12.5% increase from the current rate. These actions reflect a strategic approach aimed at enhancing financial flexibility and increasing shareholder value.
Founded in 1967, W. R. Berkley Corporation is an American commercial lines property and casualty insurance holding company. It ranks among the largest commercial line writers in the US, operating through two primary segments: Insurance, and Reinsurance and Monoline Excess. The Insurance segment contributes 88.2% to the company's business activities, while the Reinsurance segment accounts for 11.8%. The company has 8,606 employees.
Geographically, Berkley operates its commercial insurance businesses across multiple regions, including the UK, Continental Europe, South America, Canada, Mexico, Scandinavia, Asia, and Australia. In addition, its reinsurance businesses are active in the US, UK, Continental Europe, Australia, the Asia-Pacific region, and South Africa.
Berkely has consistently demonstrated strong revenue growth, achieving a CAGR of 12.6% in revenue, rising from $9.4bn in FY 21 to $13.6bn in FY 24. This revenue growth was primarily driven by a steady increase in net premiums written and investment income.
Operating income and net income have likewise soared, with operating income rising from $1.42bn to $2.34bn, and net income from $1.02bn to $1.76bn during the same period. The higher revenues bolstered operating income, alongside a relatively smaller rise in operating costs and expenses, resulting in an expansion of Berkely’s operating margins by 136bp, reaching 20.7% in FY 24.
These figures underscore Berkley's commitment to operational efficiency, distinguishing it from its competitor, The Travelers Companies, whose revenue growth has lagged behind Berkley's during the same timeframe, with a CAGR of 10.2% in revenue, 11.1% in operating income, and 10.9% in net income. Although Travelers has comparatively lower margins, they have expanded by 389bp, from 11.6% in FY 22 to 15.5% in FY 24.
Looking ahead, analysts project that Berkley will achieve an average revenue growth of 7% over the next three years, with net income expected to rise at an average rate of 6.5%. In contrast, The Travelers Companies are forecasted to experience an average revenue growth of 5.1% and net income growth of 5.6%, while maintaining an average operating margin of 13% over the same timeframe.
In terms of financial health, Berkley has effectively managed its operating cash flow, with a notable increase from $2.2bn to $3.7bn over the last three years, resulting in a cumulative FCF of over $9.0bn. This robust cash flow management has enabled the company to reduce its net debt from $1.9bn in FY 21 to $1.1bn in FY 24. The company's strategic position is further underscored by its adjusted debt-to-equity ratio, which has significantly decreased from 52% in FY 21 to 34% in FY 24. This reduction in debt levels signifies a deliberate move towards enhancing financial flexibility and stability.
Despite traditional liquidity ratios such as the current ratio (ranging from 0.34x to 0.32x) and quick ratio (from 0.24x to 0.22x) indicating constrained liquidity, these ratios are typical for insurance entities. Berkley maintains a solid capability to meet near-term policy liabilities, reflecting its prudent liquidity management within the context of industry norms.
Over the past twelve months, the stock has experienced significant upward momentum, increasing from $52.5 in June 2024 to $72.2 in June 2025, representing a notable 37% rise in price. In comparison, The Travelers Companies stock moved from $202.9 to $263.3 during the same period, reflecting a 29% increase.
At present, Berkley is trading at a P/E ratio of 16x, based on an estimated EPS of $4.50 for FY 25. This valuation is higher than its three-year average P/E of 14x and exceeds the P/E of Travelers, which stands at 14x, indicating a slight premium for Berkley. Likewise, Berkley is currently trading at EV/EBIT of 11x, based on the FY 25 EBIT estimate of $2.48b. This is marginally higher than Travelers' EV/EBIT of 10x and Berkely’s three-year historical average of 10x.
Berkley is currently covered by 16 analysts, of whom five have "Buy" ratings and nine have "Hold" ratings. The stock has reached its average target price of $70.3, suggesting limited upside potential at present.
Overall, Berkley appears to be a well-managed and financially stable entity, characterized by robust earnings, disciplined share returns, and strategic resilience. It is important to monitor how their current commitment to shareholder-friendly policies and authorized capital will impact future growth prospects.
As with any business operating within the broad spectrum of insurance, Berkley is exposed to inherent risks such as climate-driven catastrophes, capital market volatility, regulatory complexities, operational execution challenges, and competitive pressures. In addition, evolving risk factors, including potential crises stemming from geopolitical instability, could disrupt policy demand and asset values.
Joshua Cooper